Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracellular Vesicles | 4 | 2020 | 46 | 0.470 |
Why?
|
| RNA | 4 | 2019 | 574 | 0.270 |
Why?
|
| Workflow | 1 | 2025 | 118 | 0.230 |
Why?
|
| Software | 2 | 2025 | 687 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 1989 | 480 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 5 | 1993 | 61 | 0.190 |
Why?
|
| Cell-Free Nucleic Acids | 2 | 2019 | 44 | 0.190 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 1033 | 0.170 |
Why?
|
| Immunoglobulin Variable Region | 2 | 1991 | 52 | 0.170 |
Why?
|
| Thymus Gland | 5 | 1993 | 101 | 0.170 |
Why?
|
| Computational Biology | 1 | 2025 | 819 | 0.170 |
Why?
|
| Cell Communication | 1 | 2019 | 167 | 0.150 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 1756 | 0.140 |
Why?
|
| Endothelial Cells | 1 | 2020 | 502 | 0.130 |
Why?
|
| Gene Ontology | 1 | 2016 | 46 | 0.130 |
Why?
|
| Glioblastoma | 1 | 2020 | 346 | 0.130 |
Why?
|
| MicroRNAs | 2 | 2020 | 855 | 0.130 |
Why?
|
| Epigenomics | 1 | 2016 | 176 | 0.120 |
Why?
|
| Glioma | 1 | 2020 | 512 | 0.120 |
Why?
|
| Transcription, Genetic | 8 | 2004 | 1707 | 0.120 |
Why?
|
| DNA-Binding Proteins | 5 | 2004 | 2061 | 0.110 |
Why?
|
| Hypoxia | 2 | 2005 | 249 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 4 | 1992 | 1592 | 0.100 |
Why?
|
| T-Lymphocytes | 4 | 2004 | 1720 | 0.100 |
Why?
|
| Immunoglobulin alpha-Chains | 1 | 1991 | 1 | 0.090 |
Why?
|
| Immunoglobulin J-Chains | 1 | 1991 | 3 | 0.090 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1991 | 10 | 0.090 |
Why?
|
| RNA, Messenger | 7 | 2004 | 2813 | 0.090 |
Why?
|
| Immunoglobulin Joining Region | 1 | 1989 | 4 | 0.080 |
Why?
|
| Recombination, Genetic | 3 | 2005 | 448 | 0.080 |
Why?
|
| Base Sequence | 8 | 1994 | 3111 | 0.080 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 1989 | 65 | 0.080 |
Why?
|
| Molecular Sequence Data | 8 | 1994 | 3900 | 0.080 |
Why?
|
| Major Histocompatibility Complex | 1 | 1988 | 51 | 0.080 |
Why?
|
| Brain | 1 | 2020 | 3014 | 0.070 |
Why?
|
| Trans-Activators | 3 | 1997 | 801 | 0.070 |
Why?
|
| Transcription Factors | 5 | 2004 | 2603 | 0.060 |
Why?
|
| Mice | 12 | 2004 | 17750 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 6 | 1994 | 1002 | 0.060 |
Why?
|
| Cloning, Molecular | 3 | 1992 | 898 | 0.060 |
Why?
|
| DNA Repair | 2 | 2005 | 591 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 1763 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 2004 | 1339 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2520 | 0.060 |
Why?
|
| DNA Restriction Enzymes | 1 | 2004 | 122 | 0.060 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 56 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 1982 | 0.060 |
Why?
|
| User-Computer Interface | 1 | 2025 | 155 | 0.050 |
Why?
|
| Galactose | 1 | 2004 | 54 | 0.050 |
Why?
|
| Muscles | 1 | 2004 | 292 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 164 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 463 | 0.050 |
Why?
|
| Animals | 14 | 2004 | 34318 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 2880 | 0.050 |
Why?
|
| Transgenes | 1 | 2004 | 336 | 0.050 |
Why?
|
| Internet | 1 | 2025 | 375 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 585 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 429 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 1294 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2004 | 761 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2000 | 79 | 0.040 |
Why?
|
| Circulating MicroRNA | 1 | 2019 | 9 | 0.040 |
Why?
|
| Knowledge Bases | 1 | 2019 | 36 | 0.040 |
Why?
|
| Humans | 11 | 2025 | 125358 | 0.040 |
Why?
|
| Gene Expression | 3 | 1999 | 1554 | 0.040 |
Why?
|
| Body Fluids | 1 | 2019 | 47 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 239 | 0.040 |
Why?
|
| Bile Acids and Salts | 1 | 2000 | 244 | 0.040 |
Why?
|
| Zinc Fingers | 2 | 1997 | 119 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 945 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 376 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2004 | 2525 | 0.030 |
Why?
|
| Placental Lactogen | 1 | 1997 | 3 | 0.030 |
Why?
|
| Nervous System | 2 | 1995 | 128 | 0.030 |
Why?
|
| Algorithms | 1 | 2004 | 1633 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 371 | 0.030 |
Why?
|
| Web Browser | 1 | 2016 | 8 | 0.030 |
Why?
|
| Disease Progression | 2 | 2016 | 2084 | 0.030 |
Why?
|
| Trophoblasts | 1 | 1997 | 113 | 0.030 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 1993 | 6 | 0.030 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 1995 | 8 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 442 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 148 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1992 | 85 | 0.030 |
Why?
|
| Transfection | 3 | 2005 | 1076 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2016 | 302 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 1997 | 1006 | 0.030 |
Why?
|
| Aging | 2 | 1992 | 1182 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 3420 | 0.030 |
Why?
|
| Gene Targeting | 1 | 1995 | 177 | 0.030 |
Why?
|
| Databases, Factual | 1 | 1999 | 1172 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 1995 | 130 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2016 | 340 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 650 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2016 | 465 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2016 | 475 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 565 | 0.030 |
Why?
|
| Cell Cycle | 2 | 2005 | 627 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 291 | 0.020 |
Why?
|
| Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 1 | 1992 | 1 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1992 | 29 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 3 | 1997 | 35 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 1989 | 309 | 0.020 |
Why?
|
| Point Mutation | 1 | 1992 | 351 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1991 | 91 | 0.020 |
Why?
|
| Genes | 2 | 1989 | 447 | 0.020 |
Why?
|
| Spleen | 2 | 1989 | 281 | 0.020 |
Why?
|
| Cells, Cultured | 4 | 2000 | 3044 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2016 | 1051 | 0.020 |
Why?
|
| Biomarkers | 1 | 2019 | 3106 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1995 | 960 | 0.020 |
Why?
|
| Biotechnology | 1 | 1989 | 56 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1991 | 1086 | 0.020 |
Why?
|
| Liver | 1 | 1995 | 1749 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1988 | 391 | 0.020 |
Why?
|
| Kidney | 1 | 1994 | 1363 | 0.020 |
Why?
|
| Cell Line | 2 | 1989 | 2756 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 4270 | 0.020 |
Why?
|
| GATA2 Transcription Factor | 2 | 1997 | 39 | 0.020 |
Why?
|
| Rad51 Recombinase | 1 | 2005 | 29 | 0.020 |
Why?
|
| Luciferases | 1 | 2005 | 132 | 0.020 |
Why?
|
| Female | 4 | 2019 | 66815 | 0.010 |
Why?
|
| Cell Separation | 1 | 2005 | 230 | 0.010 |
Why?
|
| In Situ Hybridization | 2 | 1997 | 472 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2004 | 18 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2004 | 97 | 0.010 |
Why?
|
| Male | 5 | 2019 | 61561 | 0.010 |
Why?
|
| DNA | 1 | 1989 | 1621 | 0.010 |
Why?
|
| Rats | 2 | 2000 | 3729 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 802 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2004 | 692 | 0.010 |
Why?
|
| Iron | 1 | 2004 | 277 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2004 | 237 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2000 | 7 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2000 | 22 | 0.010 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2000 | 34 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2000 | 108 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2000 | 263 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2000 | 256 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2000 | 210 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 1999 | 134 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 29540 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 1284 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1999 | 808 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2000 | 561 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 1997 | 34 | 0.010 |
Why?
|
| Prolactin | 1 | 1997 | 114 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 1243 | 0.010 |
Why?
|
| Litter Size | 1 | 1995 | 24 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2000 | 826 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2004 | 1550 | 0.010 |
Why?
|
| Craniofacial Dysostosis | 1 | 1995 | 19 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1995 | 75 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1997 | 283 | 0.010 |
Why?
|
| Fetal Death | 1 | 1995 | 112 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1997 | 367 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 2056 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1993 | 58 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 135 | 0.010 |
Why?
|
| Cell Movement | 1 | 1997 | 854 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1995 | 455 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 1703 | 0.010 |
Why?
|
| Placenta | 1 | 1997 | 508 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1993 | 620 | 0.010 |
Why?
|
| Neural Tube Defects | 1 | 1995 | 356 | 0.010 |
Why?
|
| Gestational Age | 1 | 1995 | 1169 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1995 | 538 | 0.010 |
Why?
|
| Genotype | 1 | 1995 | 2570 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1994 | 2414 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1989 | 184 | 0.000 |
Why?
|
| Mice, Knockout | 1 | 1995 | 3754 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 2718 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1993 | 4423 | 0.000 |
Why?
|
| Mutation | 1 | 1997 | 5904 | 0.000 |
Why?
|
| Genetic Variation | 1 | 1989 | 1505 | 0.000 |
Why?
|